Position in ESPR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
New position
Shares Held
2,107,733
first reported quarter
Ownership
0.819%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIL Ltd holds $565,763,475 across 9 Drug Manufacturers - Specialty & Generic names. ESPR ranks #9 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,381,783 | $386,734,925 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,752,506 | $127,134,902 | |
| 3 | VTRS |
Viatris Inc
|
2,118,598 | $33,643,336 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
114,279 | $12,678,112 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
92,207 | $2,269,214 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,947 | $2,138,603 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
6,655 | $1,121,633 | |
| 8 | HLN |
Haleon plc
|
4,582 | $42,750 |
All Filings in ESPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 2,107,733 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||